Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality.

On sensitivity analysis, when controlling for HbA1c at listing in addition to the age at transplant, BMI at transplant, sex, hypertension, DM at listing, hyperlipidemia, CKD, and tobacco, Cox competing risk regression at 5 y again showed a lower incidence of MACE (aSHR, 0.27; P = 0.067; 95% CI, 0.06-1.10), which was not statistically significant but was trending toward significance ( Table S2, SDC, https://links.lww.com/TXD/A851 ).

also in 580 other papers